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(0.190.30mm vs. 0.320.36mm, p¼0.041), pre-PCI diameter stenosis was higher
(93.99.5% vs 89.611.5%, p¼0.037), pre PCI TIMI ﬂow was lower (pre-PCI TIMI
ﬂow non-3; 77.8% vs. 59.3%, p¼0.038), and post-PCI diameter stenosis was higher
(14.65.8% vs. 11.65.0%, p¼0.004). Multivariate analysis revealed peak CK-MB
and EF were independent predictor of TP. During three years of follow up, major
adverse cardiac events (MACE; target vessel revascularization, myocardial infarction,
death) were not different in TP + and TP – groups (11.1% vs. 16.7%, p¼0.404).
Conclusions: Despite of minor angiographic difference, TP was not associated with
three-year MACE in patients with primary coronary stent implantation due to STEMI.
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Background: No randomized studies have been conducted to investigate serial
changes of optical coherence tomography (OCT) ﬁndings following biolimus-A9-
eluting stents (BES) vs. sirolimus-eluting stents (SES) implantation.
Methods: A total of 60 patients fulﬁlling study criteria were randomly assigned into
BES (n¼30) and SES (n¼30) implantation. Of these, serial OCT evaluation at post-
procedure, 3, and 12 months was performed in 46 patients [BES (n¼22) and SES
(n¼24)] and OCT ﬁndings were compared according to the types of stents and fol-
lowed time intervals. The primary endpoint was the percentage of uncovered struts
(ratio of uncovered struts to total struts in all cross-sections with 0.2-mm interval) at 3
and 12 months and the changes (D) of percentages between 3-12 months.
Results: Although the percentages of uncovered struts at 3 months were not signiﬁ-
cantly different between two stents, BES compared to SES showed a signiﬁcantly
higher percentage of uncovered struts on 12-month OCT without signiﬁcant difference
of neointimal thickness (See Figure A). Through serial OCT evaluation, both stents
signiﬁcantly increased strut coverage from 3 to 12 months. However, BES showed
a greater D percentage of uncovered struts between 3-12 months than SES (See
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Background: Longitudinal stent deformation (LSD) is a recently reported compli-
cation of coronary intervention. However, to date, the axial integrity of stents has not
been systematically examined. This study aimed to assess the rate of LSD after
implantation utilizing intravascular ultrasound (IVUS).
Methods: A total of 218 drug-eluting stents (DES) of 197 patients with coronary
artery disease who underwent IVUS after implantation for de novo lesions were
included: 32.1% sirolimus-eluting stents (SES); 15.6% paclitaxel-eluting stents (PES);
22.9% cobalt-chromium everolimus-eluting stents (CC-EES); and 29.4% platinum-
chromium everolimus-eluting stents (PC-EES, Element platform). Stent length wasJACC Vol 62/18/Suppl B j October 27–November 1, 2013 j TCT Abstrdetermined using automatic pullback of an IVUS catheter. The absolute value of the
difference in length [IVUS-measured stent length – labeled stent length] (mm), and the
absolute value of the relative difference in length [(IVUS-measured stent length –
labeled stent length) divided by labeled length] (%) were analyzed.
Results: There was no signiﬁcant difference with regards to the absolute and relative
differences in stent length among groups. The absolute relative difference of >5% was
the lowest in the SES group compared to the other groups. Signiﬁcant (>15%)
absolute value of the relative difference in stent length was low and similar among
groups. (Table)Conclusions: This IVUS analysis proved that there are no signiﬁcant differences in
axial stent integrity between ﬁrst- and second-generation DES and among second-
generation DES. The anecdotal reports of longitudinal deformation are unsubstanti-
ated in contemporary clinical practice.
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Background: Stent underexpansion is still a concern as a cause of drug-eluting stent
(DES) failure. Although the amount of coronary calciﬁcation is considered as
a contributing factor for stent under expansion, a previous intravascular ultrasound
(IVUS) study failed to demonstrate relation between stent expansion and coronary
calciﬁcation. Optical coherence tomography (OCT) offers better quantitative assess-
ment of coronary calcium than IVUS and therefore may have potential to predict stent
expansion. Thus, the purpose of this study was to investigate whether stent expansion
could be predicted by coronary calciﬁcation assessed by OCT.
Methods: A total of 51 de novo native coronary artery lesions from 44 patients treated
by single 2nd generation DES were enrolled. Prior to stent deployment, arc of calcium
and area of calcium at the maximal calciﬁcation site within the target lesion were
measured using OCT. After successful stent implantation, OCT imaging was repeatedacts/POSTER/Intravascular Imaging and PCI B169
